Daxor Corporation (NASDAQ: DXR) Stock Information | RedChip

Daxor Corporation (NASDAQ: DXR)


$8.2900
-0.0099 ( +3.63% ) 3.7K

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Market Data


Open


$8.2900

Previous close


$8.2999

Volume


3.7K

Market cap


$38.72M

Day range


$8.0650 - $8.1850

52 week range


$7.1900 - $10.0400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jul 17, 2024
def Proxies and info statements 1 Jun 21, 2024
8-k 8K-related 13 Jun 05, 2024
nport-p Other 1 May 30, 2024
4 Insider transactions 1 Mar 27, 2024
8-k 8K-related 15 Mar 25, 2024
n-csr/a Other 3 Mar 19, 2024
n-csr Other 5 Mar 15, 2024
n-cen Other 2 Mar 15, 2024

Latest News